Literature DB >> 3696090

Determinants of osmotic phenomena created by an isolated change in extracellular solute in anuria.

A H Tzamaloukas1, W T Kyner, W R Galey.   

Abstract

The magnitude of the osmotic fluid shifts between extracellular and intracellular compartments and the changes in solute concentration that follow a change in extracellular solute are determined by the following factors: (1) the rate constant of total body osmotic fluid transfer, (2) the change in the amount of solute per liter of initial extracellular volume, (3) the initial ratio of intracellular to extracellular volume, which is usually determined by the state of extracellular volume (for the same change in the amount of solute per liter of initial extracellular volume, the changes in both extracellular volume and osmolality are greater in edematous than nonedematous states) and (4) the initial osmolality of body fluids (comparatively, the lower the initial osmolality, the larger the osmotic fluid shifts will be). However, the magnitude of the change in osmolality will be the same regardless of initial osmolality, if the other determinants are the same. If the determining factors are known, formulae applied in clinical medicine to predict the changes in solute concentration are theoretically sound. The initial intracellular to extracellular volume ratio characterizes the state of body fluids and can be computed from the changes in solute concentration provided that osmotic equilibrium exists between intracellular and extracellular compartments before and after the osmotic disturbance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3696090

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  6 in total

Review 1.  Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: a unique clinical/physiologic exercise in internal potassium balance.

Authors:  Antonios H Tzamaloukas; Todd S Ing; Moses S Elisaf; Dominic S C Raj; Kostas C Siamopoulos; Mark Rohrscheib; Glen H Murata
Journal:  Int Urol Nephrol       Date:  2010-09-19       Impact factor: 2.370

Review 2.  Dialysis-associated hyperglycemia: manifestations and treatment.

Authors:  Yijuan Sun; Maria-Eleni Roumelioti; Kavitha Ganta; Robert H Glew; James Gibb; Darlene Vigil; Catherine Do; Karen S Servilla; Brent Wagner; Jonathan Owen; Mark Rohrscheib; Richard I Dorin; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2020-01-18       Impact factor: 2.370

Review 3.  Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Authors:  Christos Argyropoulos; Helbert Rondon-Berrios; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  Cureus       Date:  2016-05-02

Review 4.  Hypertonicity: Clinical entities, manifestations and treatment.

Authors:  Helbert Rondon-Berrios; Christos Argyropoulos; Todd S Ing; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid J Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2017-01-06

5.  The Corrected Serum Sodium Concentration in Hyperglycemic Crises: Computation and Clinical Applications.

Authors:  Todd S Ing; Kavitha Ganta; Gautam Bhave; Susie Q Lew; Emmanuel I Agaba; Christos Argyropoulos; Antonios H Tzamaloukas
Journal:  Front Med (Lausanne)       Date:  2020-08-25

Review 6.  Serum Sodium Concentration and Tonicity in Hyperglycemic Crises: Major Influences and Treatment Implications.

Authors:  Antonios H Tzamaloukas; Zeid J Khitan; Robert H Glew; Maria-Eleni Roumelioti; Helbert Rondon-Berrios; Moses S Elisaf; Dominic S Raj; Jonathan Owen; Yijuan Sun; Kostas C Siamopoulos; Mark Rohrscheib; Todd S Ing; Glen H Murata; Joseph I Shapiro; Deepak Malhotra
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.